Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer.
Chi KN, Agarwal N, Bjartell A, Chung BH, Pereira de Santana Gomes AJ, Given R, Juárez Soto Á, Merseburger AS, Özgüroğlu M, Uemura H, Ye D, Deprince K, Naini V, Li J, Cheng S, Yu MK, Zhang K, Larsen JS, McCarthy S, Chowdhury S; TITAN Investigators.N Engl J Med. 2019 Jul 4;381(1):13-24. doi: 10.1056/NEJMoa1903307. Epub 2019 May 31.PMID: 31150574
Health-related quality of life after apalutamide treatment in patients with metastatic castration-sensitive prostate cancer (TITAN): a randomised, placebo-controlled, phase 3 study.
Agarwal N, McQuarrie K, Bjartell A, Chowdhury S, Pereira de Santana Gomes AJ, Chung BH, Özgüroğlu M, Juárez Soto Á, Merseburger AS, Uemura H, Ye D, Given R, Cella D, Basch E, Miladinovic B, Dearden L, Deprince K, Naini V, Lopez-Gitlitz A, Chi KN; TITAN investigators.Lancet Oncol. 2019 Nov;20(11):1518-1530. doi: 10.1016/S1470-2045(19)30620-5. Epub 2019 Sep 29.PMID: 31578173
Randomisierte, doppelblinde, placebokontrollierte Phase-III-Studie zu Pembrolizumab (MK-3475) als adjuvante Monotherapie des Nierenzellkarzinoms nach Nephrektomie (Keynote-564) – AUO-Nr. AN 45/17.
Rexer H, Doehn C, Merseburger A.Aktuelle Urol. 2019 Dec;50(6):578-580. doi: 10.1055/a-0963-6306. Epub 2019 Nov 26.PMID: 31770803
Prostatakarzinom und Nierenzellkarzinom.
Merseburger AS.Aktuelle Urol. 2019 Dec;50(6):553-554. doi: 10.1055/a-0963-6187. Epub 2019 Nov 26.PMID: 31770795
Kombinationstherapie beim Hochrisiko- nicht-muskelinvasiven Blasenkarzinom (HR-NMIBC).
Rexer H, Merseburger A Prof Dr, Bögemann M PD Dr.Aktuelle Urol. 2019 Aug;50(4):345-346. doi: 10.1055/a-0884-4480. Epub 2019 Aug 9.PMID: 31398753
Zweitlinientherapie beim metastasierten kastrationsrefraktären Prostatakarzinom (mCRPC).
Rexer H, Graefen M, Merseburger A.Aktuelle Urol. 2019 Sep;50(5):478-479. doi: 10.1055/a-0901-9007. Epub 2019 Aug 29.PMID: 31466095
[Molecular tumor board in uro-oncology].
Kübler H, Merseburger AS.Urologe A. 2019 Jul;58(7):745-746. doi: 10.1007/s00120-019-0978-2.PMID: 31292704
Zeitgleiche Entfernung von Blasenkatheter und DJ-Harnleiterschienen nach transvesikaler Prostataadenomenukleation nach Freyer.
Weber CL, Schneider M, Merseburger A.Aktuelle Urol. 2019 Dec;50(6):585. doi: 10.1055/a-0894-9313. Epub 2019 Nov 26.PMID: 31770805
[Status quo 5 years after the introduction of the new ISUP 2014/WHO 2016 prostate cancer grade groups].
Hupe MC, Offermann A, Sailer V, Merseburger AS, Perner S.Aktuelle Urol. 2019 Dec;50(6):619-624. doi: 10.1055/a-0918-9473. Epub 2019 Aug 7.PMID: 31390661
TRIM24 as an independent prognostic biomarker for prostate cancer.
Offermann A, Roth D, Hupe MC, Hohensteiner S, Becker F, Joerg V, Carlsson J, Kuempers C, Ribbat-Idel J, Tharun L, Sailer V, Kirfel J, Svensson M, Andren O, Lubczyk V, Kuefer R, Merseburger AS, Perner S.Urol Oncol. 2019 Sep;37(9):576.e1-576.e10. doi: 10.1016/j.urolonc.2019.05.006. Epub 2019 Jun 7.PMID: 31178279
[Current recommendations for the systemic treatment of metastatic renal cell carcinoma].
Kröger N, Merseburger AS, Bedke J.Aktuelle Urol. 2019 Dec;50(6):606-611. doi: 10.1055/a-0972-0788. Epub 2019 Sep 4.PMID: 31486060
Primary Results from SAUL, a Multinational Single-arm Safety Study of Atezolizumab Therapy for Locally Advanced or Metastatic Urothelial or Nonurothelial Carcinoma of the Urinary Tract.
Sternberg CN, Loriot Y, James N, Choy E, Castellano D, Lopez-Rios F, Banna GL, De Giorgi U, Masini C, Bamias A, Garcia Del Muro X, Duran I, Powles T, Gamulin M, Zengerling F, Geczi L, Gedye C, de Ducla S, Fear S, Merseburger AS.Eur Urol. 2019 Jul;76(1):73-81. doi: 10.1016/j.eururo.2019.03.015. Epub 2019 Mar 23.PMID: 30910346
Assessment of the Safety of Glucocorticoid Regimens in Combination With Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer: A Randomized, Open-label Phase 2 Study.
Attard G, Merseburger AS, Arlt W, Sternberg CN, Feyerabend S, Berruti A, Joniau S, Géczi L, Lefresne F, Lahaye M, Shelby FN, Pissart G, Chua S, Jones RJ, Tombal B.JAMA Oncol. 2019 Aug 1;5(8):1159-1167. doi: 10.1001/jamaoncol.2019.1011.PMID: 31246234
Plasma Androgen Receptor Copy Number Status at Emergence of Metastatic Castration-Resistant Prostate Cancer: A Pooled Multicohort Analysis.
Jayaram A, Wingate A, Wetterskog D, Conteduca V, Khalaf D, Sharabiani MTA, Calabrò F, Barwell L, Feyerabend S, Grande E, Martinez-Carrasco A, Font A, Berruti A, Sternberg CN, Jones R, Lefresne F, Lahaye M, Thomas S, Joshi S, Shen D, Ricci D, Gormley M, Merseburger AS, Tombal B, Annala M, Chi KN, De Giorgi U, Gonzalez-Billalabeitia E, Wyatt AW, Attard G.JCO Precis Oncol. 2019 Sep 24;3:PO.19.00123. doi: 10.1200/PO.19.00123. eCollection 2019.PMID: 32923850
Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma.
Albiges L, Powles T, Staehler M, Bensalah K, Giles RH, Hora M, Kuczyk MA, Lam TB, Ljungberg B, Marconi L, Merseburger AS, Volpe A, Abu-Ghanem Y, Dabestani S, Fernández-Pello S, Hofmann F, Kuusk T, Tahbaz R, Bex A.Eur Urol. 2019 Aug;76(2):151-156. doi: 10.1016/j.eururo.2019.05.022.PMID: 31151678
Author Correction: Urinary CE-MS peptide marker pattern for detection of solid tumors.
Belczacka I, Latosinska A, Siwy J, Metzger J, Merseburger AS, Mischak H, Vlahou A, Frantzi M, Jankowski V.Sci Rep. 2019 Sep 3;9(1):12864. doi: 10.1038/s41598-019-49304-9.PMID: 31477787
[Quality instead of quantity improves medical education].
König J, Aeishen S, Cebulla A, Bellut L, Fassbach M, Westphal J, Struck JP.Urologe A. 2019 Aug;58(8):877-880. doi: 10.1007/s00120-019-0987-1.PMID: 31267141
[Opportunities and risks of a contemporary online presence for urologists].
Cebulla A, Marx M, Struck JP.Aktuelle Urol. 2019 Aug;50(4):407-412. doi: 10.1055/a-0903-2299. Epub 2019 Jun 4.PMID: 31163463
[The importance of digitalisation in urology].
Salem J, Struck JP.Aktuelle Urol. 2019 Aug;50(4):386-391. doi: 10.1055/a-0900-3738. Epub 2019 May 15.PMID: 31091542
[The working time load of specialists and senior physicians in German urology-a critical assessment].
Struck JP, Stahl L, Braun M, Homberg R, Schönberger M, Westphal J, Salem J.Urologe A. 2019 Aug;58(8):918-923. doi: 10.1007/s00120-019-0997-z.PMID: 31300861
[Concepts to improve the balance between clinical and scientific work-a thesis paper of the working group "Young Urologists" of the German Society of Urology].
Ralla B, Leyh H, Steffens J, Burger M, Spachmann P, Borgmann H, Struck JP.Urologe A. 2019 Aug;58(8):933-937. doi: 10.1007/s00120-019-0996-0.PMID: 31297575